Three Rounds of External Quality Assessment in France to Evaluate the Performance of 28 Platforms for Multiparametric Molecular Testing in Metastatic Colorectal and Non-Small Cell Lung Cancer

Personalized medicine has gained increasing importance in clinical oncology, and several clinically important biomarkers are implemented in routine practice. In an effort to guarantee high quality of molecular testing in France, three subsequent external quality assessment rounds were organized at the initiative of the National Cancer Institute between 2012 and 2014. The schemes included clinically relevant biomarkers for metastatic colorectal (KRAS, NRAS, BRAF, PIK3CA, microsatellite instability) and non-small cell lung cancer (EGFR, KRAS, BRAF, PIK3CA, ERBB2), and they represent the first multigene/multicancer studies throughout Europe.

Source: Journal of Molecular Diagnostics - January 2, 2016 Category: Pathology Authors: Elisabeth M.C. Dequeker, Cleo Keppens, Caroline Egele, Sofie Delen, Aude Lamy, Antoinette Lemoine, Jean-Christophe Sabourin, Catherine Andrieu, Marjolijn Ligtenberg, Dominique Fetique, Bastiaan Tops, Clotilde Descarpentries, Hélène Blons, Yves Denoux, C Tags: Regular Article Source Type: research